Literature DB >> 31859610

Spinal cord injury providers' perspectives on managing sublesional osteoporosis.

Frances M Weaver1,2, Bella Etingen1, Marylou Guihan1, Cara Ray1, Michael Priebe3, Stephen Burns4,5, Laura Carbone3,6.   

Abstract

Objective: Persons with spinal cord injuries (SCI) experience rapid sublesional bone loss following injury (1, 3). Evidence on preventing/managing osteoporosis in SCI is lacking. This project examined how providers manage bone loss in SCI. Design: Telephone interviews with SCI providers. Setting: VA SCI centers and clinics. Participants: Veterans Administration SCI centers and clinics were categorized on their average number of dual-energy X-ray absorptiometry (DXA) scans (FY2014-2016). Twelve SCI providers from high and low DXA-ordering sites were interviewed. Questions included osteoporosis screening/diagnosis, prevention/treatment strategies, secondary causes of osteoporosis, and osteoporotic fracture complications. Interviews were audio-recorded, transcribed, and analyzed.
Results: Providers described a lack of standardized guidelines for managing osteoporosis in SCI. They most often screened for osteoporosis using DXA when: (1) considering use of a new device or activity, (2) for patients with a history of fracture. Some providers assumed that non-ambulatory SCI patients already have osteoporosis so infrequently ordered DXAs. Assessment of secondary causes of osteoporosis was uncommon. Fracture prevention strategies identified included weight-bearing and engaging in activities like adaptive sports. Vitamin D and calcium were frequently prescribed as a result of deficiencies identified during lab testing. Providers seldom prescribed FDA-approved medications for osteoporosis. Post-fracture complications encountered included nonunion/malunion and compartment syndrome. Providers indicated that patients often experienced psychological stress, anxiety and depression following fractures.
Conclusion: Providers described a lack of evidence for screening and management of patients with SCI and osteoporosis. Future efforts should include developing evidence-informed guidelines to aid providers in osteoporosis management.

Entities:  

Keywords:  DXA; Osteoporosis; Spinal cord injury

Year:  2019        PMID: 31859610      PMCID: PMC7480594          DOI: 10.1080/10790268.2019.1704552

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  23 in total

1.  Supralesional and sublesional bone mineral density in spinal cord-injured patients.

Authors:  M Dauty; B Perrouin Verbe; Y Maugars; C Dubois; J F Mathe
Journal:  Bone       Date:  2000-08       Impact factor: 4.398

2.  Nutritional status in chronic spinal cord injury: a systematic review and meta-analysis.

Authors:  Gary J Farkas; Marika A Pitot; Arthur S Berg; David R Gater
Journal:  Spinal Cord       Date:  2018-11-12       Impact factor: 2.772

Review 3.  Vitamin D deficiency in individuals with a spinal cord injury: a literature review.

Authors:  J L Flueck; C Perret
Journal:  Spinal Cord       Date:  2016-11-08       Impact factor: 2.772

4.  A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones.

Authors:  G C Curhan; W C Willett; E B Rimm; M J Stampfer
Journal:  N Engl J Med       Date:  1993-03-25       Impact factor: 91.245

5.  Romosozumab Treatment in Postmenopausal Women with Osteoporosis.

Authors:  Felicia Cosman; Daria B Crittenden; Jonathan D Adachi; Neil Binkley; Edward Czerwinski; Serge Ferrari; Lorenz C Hofbauer; Edith Lau; E Michael Lewiecki; Akimitsu Miyauchi; Cristiano A F Zerbini; Cassandra E Milmont; Li Chen; Judy Maddox; Paul D Meisner; Cesar Libanati; Andreas Grauer
Journal:  N Engl J Med       Date:  2016-09-18       Impact factor: 91.245

6.  Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II.

Authors:  Gary C Curhan; Walter C Willett; Eric L Knight; Meir J Stampfer
Journal:  Arch Intern Med       Date:  2004-04-26

7.  Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial.

Authors:  Sunil Goenka; Satyaranjan Sethi; Nitin Pandey; Mrinal Joshi; Rajeswari Jindal
Journal:  Spinal Cord       Date:  2018-09-26       Impact factor: 2.772

8.  Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study.

Authors:  Desmond Padhi; Mark Allison; Alan J Kivitz; Maria J Gutierrez; Brian Stouch; Christine Wang; Graham Jang
Journal:  J Clin Pharmacol       Date:  2013-12-11       Impact factor: 3.126

9.  Prevention and management of osteoporosis and osteoporotic fractures in persons with a spinal cord injury or disorder: A systematic scoping review.

Authors:  Nour Zleik; Frances Weaver; Robert L Harmon; Brian Le; Reshmitha Radhakrishnan; Wanda D Jirau-Rosaly; B Catharine Craven; Mattie Raiford; Jennifer N Hill; Bella Etingen; Marylou Guihan; Michael H Heggeness; Cara Ray; Laura Carbone
Journal:  J Spinal Cord Med       Date:  2018-05-10       Impact factor: 1.985

10.  Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates.

Authors:  P D Miller; N Pannacciulli; J P Brown; E Czerwinski; B S Nedergaard; M A Bolognese; J Malouf; H G Bone; J-Y Reginster; A Singer; C Wang; R B Wagman; S R Cummings
Journal:  J Clin Endocrinol Metab       Date:  2016-06-06       Impact factor: 5.958

View more
  1 in total

Review 1.  The Effects of Exercise and Activity-Based Physical Therapy on Bone after Spinal Cord Injury.

Authors:  Tommy W Sutor; Jayachandra Kura; Alex J Mattingly; Dana M Otzel; Joshua F Yarrow
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.